
Apollo Endosurgery APEN
Annual report 2022
added 03-30-2023
Apollo Endosurgery Interest Expense 2011-2026 | APEN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.67 M | 8.32 M | 5.25 M | 4.05 M | 4.06 M | 4.51 M | 18.2 M | 10 M | 18 | 26.6 K | -90.7 K | -4.09 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.2 M | -90.7 K | 4.92 M |
Quarterly Interest Expense Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.16 M | - | 1.22 M | - | 1.34 M | 1.33 M | 1.35 M | - | 1.34 M | 1.32 M | 1.24 M | - | 1.22 M | 669 K | 959 K | - | 1 M | 1.02 M | 960 K | - | 1.01 M | 1.05 M | 1.48 M | - | 1.53 M | 2.52 M | 2.83 M | - | 40 | 40 | - | - | 18 | 18 | - | - | -420 | 27 K | 27 K | - | -47.9 K | 33.3 K | -28.6 K | - | 31.2 K | 4.11 K | -43.6 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.83 M | -47.9 K | 805 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.29 | 3.58 % | $ 1.69 B | ||
|
AxoGen
AXGN
|
167 K | $ 33.05 | 3.41 % | $ 1.52 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 179.93 | 3.92 % | $ 13.5 B | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.43 | 2.14 % | $ 1.68 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 287.63 | 3.05 % | $ 8.12 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.38 | 2.42 % | $ 127 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 38.99 | 3.74 % | $ 5.81 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 63.02 | 2.04 % | $ 93.3 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.88 | 13.77 % | $ 280 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.97 | 4.23 % | $ 1.2 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
78 K | $ 24.7 | 2.4 % | $ 209 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.44 | 1.74 % | $ 171 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 64.47 | 2.69 % | $ 3.52 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.9 | 3.55 % | $ 70.6 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.92 | 5.95 % | $ 397 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 92.74 | 2.62 % | $ 12.5 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.28 | 4.27 % | $ 906 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.45 | 4.03 % | $ 374 M | ||
|
Myomo
MYO
|
-668 K | $ 0.72 | 4.35 % | $ 30.1 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 54.65 | 1.2 % | $ 1.61 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 38.52 | 4.83 % | $ 1.2 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 87.51 | 2.78 % | $ 3.04 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.67 | -0.05 % | $ 122 M |